Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03067285 |
|---|---|
| Brief Title: | A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study (DREAM) |
| First Submitted : | February 14, 2017 |
| First Submitted that Met QC Criteria : | February 24, 2017 |
| First Posted : | March 1, 2017 |
| Last Update Submitted that Met QC Criteria : | August 26, 2019 |
| Last Update Posted : | August 27, 2019 (Estimate) |